| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 29 |
| 1 | ADALIMUMAB | 25 |
| 2 | ADALIMUMAB-AATY | 24 |
| 3 | ADALIMUMAB-ADAZ | 23 |
| 4 | ADALIMUMAB-FKJP | 23 |
| 5 | PEMBROLIZUMAB | 13 |
| 6 | PREDNISONE | 12 |
| 7 | INFLIXIMAB | 11 |
| 8 | MYCOPHENOLATE MOFETIL | 11 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETRORELIX ACETATE | 3 | 0.0047 |
| 1 | FOLLITROPIN ALFA | 3 | 0.0015 |
| 2 | MENOTROPINS | 3 | 0.0014 |
| 3 | BEDAQUILINE FUMARATE | 1 | 0.0007 |
| 4 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 5 | ADALIMUMAB-FKJP | 23 | 0.0005 |
| 6 | ADALIMUMAB-AATY | 24 | 0.0005 |
| 7 | PERPHENAZINE | 1 | 0.0005 |
| 8 | ADALIMUMAB-ADAZ | 23 | 0.0004 |
| 9 | CLADRIBINE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 16 | 0.0002 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 4 | Progesterone [EPC] | 3 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 38 | 0.0001 |
| 6 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 8 | Tetracycline-class Drug [EPC] | 5 | 0.0001 |
| 9 | Complement Inhibitor [EPC] | 3 | 0.0001 |